News from amarantus bioscience, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Feb 04, 2014, 08:30 ET

Amarantus Announces Positive Phase 2a Data for Eltoprazine in Adult ADHD

 - 36 out of 47 adult subjects (77%) completed the double-blind placebo controlled, multiple dose, crossover study - Primary...

Feb 28, 2013, 08:00 ET

Amarantus BioScience to Present MANF Parkinson's Data at the 15th Annual American Society for Experimental NeuroTherapeutics

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Feb 25, 2013, 10:32 ET

Amarantus BioScience and Banyan Biomarkers to Present Poster of MANF Data at The 3rd Annual Traumatic Brain Injury Conference

 Amarantus BioScience, Inc. (OTCQB:AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated...

Feb 08, 2013, 08:30 ET

Amarantus BioScience to Present at the 15th Annual BIO CEO & Investor Conference

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Feb 06, 2013, 09:58 ET

OneMedPlace Research Releases Update to Research Report on Amarantus BioScience

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Feb 04, 2013, 09:27 ET

Amarantus BioScience Reports Statistical Significance Achieved for MANF Striatal Reinnervation in Neurorestoration Animal Model of Parkinson's Disease

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Jan 31, 2013, 06:00 ET

Amarantus BioScience Secures an Additional $1.4 Million in Financing Commitments

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Jan 28, 2013, 09:29 ET

Amarantus BioScience Launches New Website

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Jan 16, 2013, 08:36 ET

Amarantus BioScience Announces Publication of Independent Peer-Reviewed Data for Receptor and Secretion Pathways related to MANF

Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated...

Jan 10, 2013, 11:55 ET

Amarantus BioScience Announces Biotech Showcase 2013 Corporate Presentation is Available Online

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Jan 09, 2013, 08:31 ET

Amarantus BioScience Announces Positive Efficacy Data for MANF in a Nigral Delivery Neurorestoration Animal Model of Parkinson's Disease

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Jan 08, 2013, 09:51 ET

Amarantus Bioscience Neurorestoration Animal Data Presentation to be Webcast Live Today from OneMedForum 2013 at 4:40pm Eastern

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments for diseases associated with protein...

Dec 27, 2012, 08:43 ET

Amarantus BioScience to Present at Biotech Showcase 2013

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company developing treatments and diagnostics for diseases associated with...

Dec 26, 2012, 08:36 ET

Amarantus BioScience Acquires Neurodegenerative Diagnostic Intellectual Property Portfolio from Power3 Medical Products

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company developing treatments and diagnostics for diseases associated with...

Dec 20, 2012, 10:03 ET

Amarantus Bioscience to Present Parkinson's Neurorestoration Animal Data Results at OneMedForum

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments for diseases associated with protein...

Dec 14, 2012, 07:20 ET

Amarantus BioScience Licenses LymPro Alzheimer's Disease Diagnostic Blood Test

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments for diseases associated with protein...

Dec 11, 2012, 06:00 ET

Amarantus Bioscience Launches Online Corporate Communication Channels

Amarantus Bioscience, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic...

Dec 06, 2012, 07:52 ET

Amarantus Bioscience to Present at OneMedForum 2013

 Amarantus Bioscience, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and...

Dec 04, 2012, 09:41 ET

Amarantus Appoints Super Bowl Champion Toi Cook to Board of Advisors to Advance TBI Program

 Amarantus Bioscience, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and...

Dec 03, 2012, 17:10 ET

Amarantus Completes Name Change and CUSIP Change

 Amarantus Bioscience, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and...